Test Price
2,800 AED✅ Home Collection Available
AIFM1 Gene (CMTX4) Genetic Test in UAE | 2,800 AED | Next-Generation Sequencing
Executive Summary & Core Metrics
✓ 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Lab (DNA Labs UAE)
🩸 VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (8 AM – 11 PM Daily)
📞 Post-Test Clinical Guidance & Direct Billing Verification: WhatsApp +971 54 548 8731
Test Overview & Methodology
The AIFM1 gene test utilizes Next-Generation Sequencing (NGS) to detect pathogenic variants in the AIFM1 gene responsible for X-linked Charcot-Marie-Tooth disease type 4 (CMTX4). This test provides definitive molecular diagnosis, enabling accurate genetic counseling, prognosis estimation, and early intervention for at-risk family members.
| Feature | Our AIFM1 CMTX4 NGS Test | Standard Genetic Panel |
|---|---|---|
| Precision | 100% coding region & intron-exon boundaries of AIFM1 gene | Limited coverage; may miss deep intronic & novel variants |
| Methodology | Illumina-based NGS with bioinformatic analysis aligned to ACMG guidelines | Sanger sequencing or targeted genotyping only for known hot spots |
| Turnaround Time | 3 – 4 weeks (rapid reporting for urgent neurology referrals) | 4 – 6 weeks typical |
| Clinical Support | Post-test telephonic guidance by a DHA-licensed clinical geneticist | Often report-only without interpretation |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I emphasize that while this NGS assay provides a definitive molecular diagnosis for CMTX4, it must always be interpreted in conjunction with a detailed neurological examination, family history, and electromyography findings. Genetic testing guides prognosis and family planning but does not replace clinical assessment.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Protocols
⚠️ Important Safety Advisory
Do not discontinue any prescribed medication or alter your treatment plan without consulting your doctor. This genetic test provides diagnostic information only and does not offer immediate therapeutic recommendations. Always discuss results with a qualified healthcare provider.
Exclusion Criteria & Emergency Red Flags
- Inability to give informed consent or lack of legal guardian (minors require court-authorised consent as per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Allogeneic blood transfusion within the last 2 weeks – may interfere with DNA purity.
- Severe hemophilia or bleeding disorder that contraindicates venipuncture.
- Emergency Red Flags: Sudden respiratory distress, progressive dysphagia, or altered consciousness – call 998 immediately.
Patient FAQ & Clinical Guidance
1. What is the AIFM1 gene test for CMTX4, and who should consider it?
The AIFM1 gene test detects pathogenic variants causing X-linked Charcot-Marie-Tooth neuropathy type 4. It is indicated for individuals with progressive distal muscle weakness and sensory loss, a positive family history of CMT, or those seeking carrier screening. Early diagnosis enables targeted management and reproductive counseling.
2. How is the test performed, and what is the turnaround time?
A simple blood sample is collected via VIP mobile phlebotomy between 8 AM and 11 PM, with temperature-controlled cold-chain transport to our ISO 9001:2015 accredited laboratory. The sample undergoes NGS analysis, and results are reported within 3 to 4 weeks, followed by telephonic genetic counseling.
3. Does insurance cover this test, and is data privacy guaranteed?
We offer direct billing verification via WhatsApp at +971545488731. Your data is protected under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted and stored on secure UAE-based servers.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
This test is conducted in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability (informed consent and safety)
Our laboratory holds ISO 9001:2015 Certification and is licensed by the Dubai Health Authority (DHA Facility License No. 1143). All genetic data is encrypted, anonymized, and stored securely within the UAE.
Clinical & Logistical Metadata
| Test Name | AIFM1 Gene (CMTX4) Sequencing – Next-Generation Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (Illumina platform) with bioinformatic analysis |
| ICD-10-CM Code | G60.0 (Hereditary motor and sensory neuropathy) |
| LOINC Code | 94893-5 (AIFM1 gene targeted mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians